Cancer Program

We strive for a future where no child will die from brain cancer because we have developed new therapies that will cure their disease.

The main aim of our Leukaemia Translational Research Team is to test innovative therapeutic approaches, with a focus on clinical translation of this knowledge, to improve the outcomes of children suffering from leukaemia.

The Translational Genomics in Leukaemia team is focused on identifying the causes of leukaemia, with the goal of developing new targeted treatments to improve quality of care and long-term survival for all children with leukaemia.

Researchers within the Cancer Immunology and Biology group are working to develop safer immunotherapy and personalised medicine treatments across various deadly childhood cancers, including brain cancer, sarcoma, leukaemia, and neuroblastoma.

We think all kids with Sarcoma should be able to lead happy, healthy lives! To achieve this, we aim to discover and develop safer and more effective treatments by doing inventive and rigorous research. We focus on addressing high relapse rates using a combination of unique pre-clinical models, patient samples and systems immunology.